Concomitant radiochemotherapy with Mitomycin C and Cisplatin in inoperable carcinoma of the head and neck: preliminary results of phase II study

被引：0
|
作者：
Strojan, P.
Zakotnik, B.
Smid, L.
Karner, K.
Soba, E.
机构：
[1] Inst Oncol, Dept Radiat Oncol, Ljubljana, Slovenia
[2] Inst Oncol, Dept Med Oncol, Ljubljana, Slovenia
[3] Ctr Clin, Dept Otorhinolaryngol & Cervicofacial Surg, Ljubljana, Slovenia
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [31] Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer. Preliminary report
    Smid, L.
    Lesniear, H.
    Zakotnik, B.
    Soba, E.
    Budihna, M.
    Furlan, L.
    Zargi, M.
    Rudolf, Z.
    International Journal of Radiation Oncology, Biology, Physics, 1995, 32 (03):
  • [32] Induction Chemotherapy with Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy in Patients with Inoperable Non-nasopharyngeal Carcinoma of the Head and Neck
    Fountzilas, George
    Bamias, Aristotelis
    Kalogera-Fountzila, Anna
    Karayannopoulou, Georgia
    Bobos, Mattheos
    Athanassiou, Eleni
    Kalogeras, Konstantine T.
    Tolis, Christos
    Tsekeris, Periklis
    Papakostas, Pavlos
    Vamvouka, Chrysanthi
    Zaramboukas, Thomas
    Kosmidis, Paris
    Zamboglou, Nikolaos
    Misailidou, Despina
    ANTICANCER RESEARCH, 2009, 29 (02) : 529 - 538
  • [33] Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study
    Perri, F.
    Muto, P.
    Schiavone, C.
    Ionna, F.
    Aversa, C.
    Maiolino, P.
    Cavalcant, E.
    Sandomenico, F.
    Caponigro, F.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 178 - 179
  • [34] Preliminary results of a phase II study to evaluate gefitinib combined with docetaxel and cisplatin in patients with recurrent and/or metastatic squamous-cell carcinoma of the head and neck.
    Belón, J
    Irigoyen, A
    Rodríguez, I
    Escobar, Y
    Alonso, JL
    Pastor, P
    Valdivia, J
    Concha, A
    Nuevo, J
    Bovio, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 515S - 515S
  • [35] Phase-II study on radiochemotherapy in patients with inoperable NSCLC and risk factors with vinorelbin and cisplatin/carboplatin
    Semrau, S
    Dietrich, U
    Bier, A
    Thierbach, U
    Ketterer, P
    Fietkau, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 38 - 39
  • [36] Definitive hyperfractionated accelerated radiochemotherapy for inoperable bead and neck cancers - Preliminary experiences and results
    Olschewski, T
    Bajor, K
    Seegenschmiedt, MH
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 43 - 43
  • [37] A phase II study of docetaxel and cisplatin in patients with squamous cell carcinoma of the head and neck (SCCN)
    Forastiere, A
    Glisson, B
    Murphy, B
    Frenette, G
    O'Connell, B
    ANNALS OF ONCOLOGY, 1998, 9 : 75 - 75
  • [38] A Phase II Study Of Concomitant Hyperfractionated Radiation Therapy And Double Dose Intra-Arterial Cisplatin For Squamous Cell Carcinoma Of The Head And Neck
    Regine, William F.
    Valentino, Joseph
    Arnold, Susanne M.
    Sloan, David
    Kenady, Daniel
    Strottmann, James
    Mohiuddin, Mohammed
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2002, 1 (02) : 133 - 140
  • [39] Phase I-II study concomitant taxol and carboplatin with radiotherapy in advanced head and neck cancer.: Preliminary results.
    Jaén, A
    Martos, M
    González, E
    Medina, B
    Sánchez, P
    Cabrero, A
    Porras, I
    Mohedano, N
    Capllonch, M
    Fernández, M
    Lozano, A
    Casanova, MA
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S62 - S62
  • [40] Phase I-II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer
    Harrington, KJ
    Lewanski, CR
    Northcote, AD
    Whittaker, J
    Wellbank, H
    Vile, RG
    Peters, AM
    Stewart, JSW
    ANNALS OF ONCOLOGY, 2001, 12 (04) : 493 - 496
12345